Isoquinoline and Quinazoline Urea Analogues as Antagonists for the Human Adenosine A3Receptor
- 11 May 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (11) , 2227-2238
- https://doi.org/10.1021/jm000002u
Abstract
Isoquinoline and quinazoline urea derivatives were found to bind to human adenosine A3 receptors. Series of N-phenyl-N‘-quinazolin-4-ylurea derivatives and N-phenyl-N‘-isoquinolin-1-ylurea derivatives were synthesized and tested in radioligand binding assays on their adenosine receptor affinities. A structure−affinity analysis indicated that on the 2-position of the quinazoline ring or the equivalent 3-position of the isoquinoline ring a phenyl or heteroaryl substituent increased the adenosine A3 receptor affinity in comparison to unsubstituted or aliphatic derivatives. Furthermore, the structure−affinity relationship of substituted phenylurea analogues was investigated. Substituents such as electron-withdrawing or electron-donating groups were introduced at different positions of the benzene ring to probe electronic and positional effects of substitution. Substitution on the 3- or 4-position of the phenyl ring decreased the adenosine A3 receptor affinity. Substitution at position 2 with an electron-donating substituent, such as methyl or methoxy, increased human adenosine A3 receptor affinity, whereas substitution on the 2-position with an electron-withdrawing substituent did not influence affinity. Combination of the optimal substituents in the two series had an additive effect, which led to the potent human adenosine A3 receptor antagonist N-(2-methoxyphenyl)-N‘-(2-(3-pyridyl)quinazolin-4-yl)urea (VUF5574, 10a) showing a Ki value of 4 nM and being at least 2500-fold selective vs A1 and A2A receptors. Compound 10a competitively antagonized the effect of an agonist in a functional A3 receptor assay, i.e., inhibition of cAMP production in cells expressing the human adenosine A3 receptor; a pA2 value of 8.1 was derived from a Schild plot. In conclusion, compound 10a is a potent and selective human adenosine A3 receptor antagonist and might be a useful tool in further characterization of the human A3 receptor.Keywords
This publication has 12 references indexed in Scilit:
- Synthesis and Biological Activities of Flavonoid Derivatives as A3 Adenosine Receptor AntagonistsJournal of Medicinal Chemistry, 1996
- 6-Phenyl-1,4-dihydropyridine Derivatives as Potent and Selective A3 Adenosine Receptor AntagonistsJournal of Medicinal Chemistry, 1996
- The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cellsJournal of Biological Chemistry, 1993
- Reaction of nitriles under acidic conditions. Part VI. Synthesis of condensed 4‐chloro‐ and 4‐aminopyrimidines from ortho‐aminonitrilesJournal of Heterocyclic Chemistry, 1990
- Influence of the molecular structure of N6-(ω-aminoalkyl)adenosines on adenosine receptor affinity and intrinsic activityEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- Hydroxide‐catalyzed synthesis of heterocyclic aromatic amine derivatives from nitrilesJournal of Heterocyclic Chemistry, 1982
- Relation of structures and microbiological activities of the 16-membered macrolidesJournal of Medicinal Chemistry, 1972
- Quinazolines and 1,4-benzodiazepines. LII. Rearrangement of 1-alkyl-7-chloro-1,3-dihydro-3-acetoxy-3-methyl-5-phenyl-2H-1,4-benzodiazepin-2-ones with baseThe Journal of Organic Chemistry, 1971
- Piperidylquinolizidines Derived from SparteineThe Journal of Organic Chemistry, 1961
- 286. The chemistry of simple heterocyclic systems. Part III. Basic centres of 4-substituted quinazoline derivativesJournal of the Chemical Society, 1949